Drugmakers seek tweaks to ICH guidance on continuous manufacturing

Eli Lilly, Gilead, Thermo Fisher and other industry groups and nonprofits like BIO and USP are seeking some slight changes and more clarity from the International Council of Harmonisation on its new guidance related to continuous manufacturing.

The guidance, known as Q13, focuses on continuous manufacturing...

Click to view original post